Sha Lin

2.9k total citations · 1 hit paper
32 papers, 516 citations indexed

About

Sha Lin is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Sha Lin has authored 32 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Sha Lin's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (5 papers) and Hepatitis B Virus Studies (4 papers). Sha Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (5 papers) and Hepatitis B Virus Studies (4 papers). Sha Lin collaborates with scholars based in China, Hong Kong and United States. Sha Lin's co-authors include Bo Chen, Bin Lou, Weilin Mao, Jian Fan, Feifei Lv, Siming Lu, Yu Chen, Yajie Fu, Bo Ye and Yuemei Chen and has published in prestigious journals such as Journal of Molecular Biology, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Sha Lin

30 papers receiving 504 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery

2024 65 citations Petrina Kamya, Ivan V. Ozerov et al. Journal of Chemical Information and Modeling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sha Lin China	14	181	159	138	75	70	32	516
Le‐Feng Chen China	12	117 0.6×	81 0.5×	71 0.5×	53 0.7×	49 0.7×	25	397
Thierry Lafont France	15	78 0.4×	113 0.7×	107 0.8×	48 0.6×	197 2.8×	24	607
Kuan‐Yu Chen Taiwan	13	126 0.7×	194 1.2×	109 0.8×	31 0.4×	50 0.7×	31	454
Sukriti Baweja India	12	139 0.8×	99 0.6×	107 0.8×	16 0.2×	21 0.3×	28	367
Keita Sakamoto Japan	16	110 0.6×	255 1.6×	75 0.5×	61 0.8×	171 2.4×	49	773
HS Kim South Korea	13	99 0.5×	136 0.9×	71 0.5×	16 0.2×	53 0.8×	24	576
Mettine H.A. Bos Netherlands	20	68 0.4×	162 1.0×	47 0.3×	21 0.3×	41 0.6×	56	975
Yueming He China	14	103 0.6×	281 1.8×	102 0.7×	25 0.3×	122 1.7×	41	625
Xinyao Tian China	11	97 0.5×	146 0.9×	38 0.3×	14 0.2×	25 0.4×	18	294

Countries citing papers authored by Sha Lin

Since Specialization

Citations

This map shows the geographic impact of Sha Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Lin more than expected).

Fields of papers citing papers by Sha Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sha Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Lin. The network helps show where Sha Lin may publish in the future.

Co-authorship network of co-authors of Sha Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Sha Lin. A scholar is included among the top collaborators of Sha Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sha Lin. Sha Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Wei, et al.. (2025). Thrombotic Thrombocytopenic Purpura During Anti-Tuberculosis Therapy: A Case Report and Literature Review. Infection and Drug Resistance. Volume 18. 6051–6058.

Li, Juan, et al.. (2025). Exploring the heterogeneity of cancer-related fatigue in advanced hepatocellular carcinoma patients via latent profiles and influencing factors. Scientific Reports. 15(1). 35151–35151.

Lin, Sha, et al.. (2025). Timestamp calibration for time-series single cell RNA-seq expression data. Journal of Molecular Biology. 437(9). 169021–169021. 1 indexed citations

Kamya, Petrina, Ivan V. Ozerov, Frank W. Pun, et al.. (2024). PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery. Journal of Chemical Information and Modeling. 64(10). 3961–3969. 65 indexed citations breakdown →

Fang, Zhixiong, Qiong Liu, Wei Tang, et al.. (2023). Experience in the diagnosis and treatment of pneumonia caused by infection with Tropheryma whipplei: A case series. Heliyon. 9(6). e17132–e17132. 8 indexed citations

Li, Juan, et al.. (2023). The relationship of exercise and cancer-related fatigue in patients with advanced liver cancer: a cross-sectional study. Scientific Reports. 13(1). 17341–17341. 4 indexed citations

Chen, Jianhong, et al.. (2022). The runoff changes are controlled by combined effects of multiple regional environmental factors in the alpine hilly region of Northwest China. The Science of The Total Environment. 862. 160835–160835. 13 indexed citations

Huang, Wei, Zhixiong Fang, Sha Lin, et al.. (2022). The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China. International Journal of Infectious Diseases. 122. 321–326.2. 10 indexed citations

Lin, Sha, et al.. (2022). Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report. Frontiers in Cardiovascular Medicine. 9. 872172–872172. 1 indexed citations

10.

Ye, Bo, Yifei Shen, Hui Chen, et al.. (2022). Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease. Scientific Reports. 12(1). 14428–14428. 13 indexed citations

11.

Yang, Yang, Zhixiong Fang, Wei Huang, et al.. (2022). Safety of a Novel ESAT6-CFP10 skin test compared with tuberculin skin test in a double-blind, randomized, controlled study. BMC Infectious Diseases. 22(1). 780–780. 6 indexed citations

12.

Zheng, Shufa, Qianda Zou, Dan Zhang, et al.. (2021). Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis. Clinica Chimica Acta. 524. 132–138. 10 indexed citations

13.

Lou, Bin, Feifei Lv, Quan Yuan, et al.. (2021). Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation. Frontiers in Immunology. 12. 710528–710528. 6 indexed citations

14.

Lou, Bin, Guangdie Yang, Chuangen Guo, et al.. (2019). Role of <b><i>Aspergillus fumigatus-</i></b>Specific IgE in the Diagnosis of Allergic Bronchopulmonary Aspergillosis. International Archives of Allergy and Immunology. 178(4). 338–344. 13 indexed citations

15.

Chen, Bo & Sha Lin. (2017). Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine. 96(24). e7142–e7142. 58 indexed citations

16.

Sun, Qinqin, et al.. (2016). AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis. Medicine. 95(9). e2946–e2946. 15 indexed citations

17.

Fan, Jian, Bin Lou, Wei Chen, et al.. (2014). Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest. Tumor Biology. 35(11). 11523–11532. 56 indexed citations

18.

Lou, Bin, Jian Fan, Keyi Wang, et al.. (2013). N1-guanyl-1,7-diaminoheptane (GC7) enhances the therapeutic efficacy of doxorubicin by inhibiting activation of eukaryotic translation initiation factor 5A2 (eIF5A2) and preventing the epithelial–mesenchymal transition in hepatocellular carcinoma cells. Experimental Cell Research. 319(17). 2708–2717. 32 indexed citations

19.

Lou, Yufeng, et al.. (2012). Changes in peripheral T-lymphocyte subsets in acute-on-chronic liver failure patients with artificial liver support system.. PubMed. 59(115). 814–7. 7 indexed citations

20.

Mao, Weilin, Bo Ye, Sha Lin, et al.. (2010). Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients With Plasma Exchange Treatment. ASAIO Journal. 56(5). 475–478. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact